HIPS Helmholtz Institut für Pharmazeutische Forschung Saarland

HIPS Symposium 2022   May 12, 2022

on pharmaceutical sciences devoted to infection research

HIPS symposium The HIPS symposium 2022 will take place in the form of a 1-day online meeting. The symposium brings together renowned scientists and young investigators from three pharmaceutical communities: natural products, medicinal chemistry and drug delivery. It provides a forum for scientists to exchange ideas while crossing boundaries of classical disciplines. The event comprises scientific lectures by leading experts in the field, short lectures (upgrades will be offered to poster contributors), and online poster sessions. All lectures will be broadcasted for the remote participants.

Conference venue: Online format - live broadcast from HIPS at Saarland University Campus in Saarbrücken, Germany. Registration is free of charge. Details about the setting will be sent to registered participants before the event.

✉ Contact us by email with any questions. We are looking forward to your participation in the HIPS symposium 2022!

The HIPS 2022 symposium is over. We are looking forward to welcome you at the next event in 2023. Program to be announced!


Symposium day schedule:
9:15 - 16:15 h (CEST)
Scientific presentations by invited speakers, short talks and poster presentations.

There will be time to interact with the speakers and the poster presenters in dedicated online sessions.

▶ Access to all events is through the Zoom link in the online program for registered participants (enter with meeting key).

▶ Talks (but not discussion roundtables and poster sessions) are also streamed live on our YouTube channel.

Confirmed speakers

mRNA based vaccines – CV2Cov
WILHELM BOLAND - Max Planck Institute for Chemical Ecology:
The Fate of Chlorophyll in Phytophagous Insects Goes Beyond Nutrition
CHRISTIAN LERNER - Hoffmann-La Roche:
Influenza Endonuclease Inhibitors
MATTHIAS RAREY - University of Hamburg:
Computational Exploration of Chemical Space
EMILIE RACINE - Nosopharm:
From worms to clinical candidate: the story of Odilorhabdins, a new class of antimicrobial agents
WILFRED VAN DER DONK - University of Illinois:
Connections between Natural Product Biosynthesis and Mammalian Biology
⚑ Find HIPS   ✉ Email us   ☂ Data privacy statement

This website is maintained by HIPS, part of Helmholtz Centre for Infection Research (HZI), Braunschweig/Germany.